Responses
Psoriatic arthritis
Original research
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials
Compose a Response to This Article
Other responses
No responses have been published for this article.